title: Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer.
abstract: Minimally invasive therapy for upper tract urothelial cell cancer has assumed an important role in the management of this relatively uncommon genitourinary malignancy. In this review, current standards for patient selection, surgical approach, as well as overall outcomes will be discussed. Moreover, the use of intraluminal agents in upper tract disease is examined along with its efficacy and associated complications.
authors.affiliation: 1 Yale University School of Medicine , New Haven, Connecticut.
authors.forename: Shu
authors.initials: S
authors.lastname: Pan
authors.affiliation: 2 Smith Institute for Urology, Northwell-Hofstra University , New Hyde Park, New York.
authors.forename: Arthur D
authors.initials: AD
authors.lastname: Smith
authors.affiliation: 1 Yale University School of Medicine , New Haven, Connecticut.
authors.forename: Piruz
authors.initials: P
authors.lastname: Motamedinia
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000601:surgery*; D006801:Humans; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D009392:Nephrectomy / Q000379:methods; D009403:Nephrostomy, Percutaneous / Q000379:methods; D059351:Organ Sparing Treatments / Q000379:methods; D018579:Patient Selection; D014516:Ureteral Neoplasms / Q000601:surgery*; D018666:Ureteroscopy / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000601:surgery; D019459:Urothelium / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents
keywords: endoscopic; intraluminal; percutaneous; upper tract; ureteroscopic; urothelial cell carcinoma